Synbiotics said Monday that total revenue for...

Synbiotics said Monday that total revenue for the first quarter ended June 30 rose by 20%, to $2.4 million, up from $2 million during the previous first quarter. Sales of monoclonal antibody-based products reached $750,000 during the first quarter, a 22% increase over sales during the same quarter a year ago. Synbiotics will report net income in about two weeks, according to a spokesman.